Hypha Labs, Inc.
FUNI
$0.0263
-$0.0017-6.07%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 289.26% | 1,116.28% | 522.26% | 29.58% | -46.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 289.26% | 1,116.28% | 522.26% | 29.58% | -46.01% |
| Operating Income | -289.26% | -1,116.28% | -522.26% | -29.58% | 46.01% |
| Income Before Tax | -578.47% | -337.65% | -93.14% | 27.51% | 74.10% |
| Income Tax Expenses | -170.84% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -508.12% | -340.08% | -95.16% | 25.70% | 71.41% |
| Earnings from Discontinued Operations | -100.00% | -76.07% | -38.35% | 68.93% | 1,349.01% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -434.85% | -456.46% | -418.27% | 93.08% | 154.97% |
| EBIT | -289.26% | -1,116.28% | -522.26% | -29.58% | 46.01% |
| EBITDA | -8,701.74% | -6,283.38% | -918.63% | 26.59% | 97.32% |
| EPS Basic | -342.59% | -352.70% | -321.43% | 106.25% | 148.21% |
| Normalized Basic EPS | -109.09% | -314.29% | -145.83% | 8.04% | 46.90% |
| EPS Diluted | -421.30% | -398.65% | -442.86% | 75.89% | 142.52% |
| Normalized Diluted EPS | -109.09% | -314.29% | -145.83% | 8.04% | 46.90% |
| Average Basic Shares Outstanding | 37.57% | 30.07% | 20.79% | 15.54% | 11.29% |
| Average Diluted Shares Outstanding | 37.57% | 30.07% | 20.79% | 15.54% | 11.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |